Biocryst Pharmaceuticals Inc (BCRX)
Net Income Growth
1441.69%
Quarterly · Period ending:
BCRX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported1441.69%period ending
Latest reported1441.69%period ending
BCRX Quarterly Net Income YoY % (-81.25% → 1441.69%)
Year-over-year change
High-resolution chart · PNG
BCRX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 1,441.6912% | |
| -2,255,762.5% | |
| 1,017.5033% | |
| 191.919% | |
| 140.1215% | |
| 100.0904% | |
| 56.5939% | |
| 61.1801% | |
| 83.1745% | |
| 33.664% | |
| 13.7124% | |
| 14.9835% | |
| -27.977% | |
| 28.1188% | |
| -302.3905% | |
| 27.6883% | |
| -36.254% | |
| -15.4191% | |
| 70.6098% | |
| -27.5095% | |
| -11.8916% | |
| -70.9726% | |
| -2,207.132% | |
| -22.6724% | |
| -2.5991% | |
| -21.0762% | |
| 90.4418% | |
| -27.0129% | |
| -103.9954% | |
| -20.4717% | |
| -40.3674% | |
| -95.5663% | |
| -9.2384% | |
| -81.2856% | |
| -333.9996% | |
| -31.2804% | |
| -3.716% | |
| 37.7234% | |
| 75.1696% | |
| 21.1545% | |
| -432.1975% | |
| -50.5671% | |
| -55.3718% | |
| -67.4608% | |
| 133.4562% | |
| -49.5906% | |
| -114.9936% | |
| -9.1239% | |
| -20.35% | |
| -124.9667% | |
| 50.8821% | |
| 17.5155% | |
| 0.8472% | |
| 25.5453% | |
| 16.2144% | |
| 32.9138% | |
| 24.5529% | |
| 53.5426% | |
| -29.3183% | |
| -33.0909% | |
| -59.6292% | |
| -402.0039% | |
| -167.328% | |
| -2.2302% | |
| -17.3768% | |
| 72.0728% | |
| 50.455% | |
| -18.1434% | |
| 31.6705% | |
| 29.0579% | |
| 541.0039% | |
| 18.1082% | |
| -82.5219% | |
| -48.4193% | |
| 77.278% | |
| 29.6033% | |
| 30.9432% | |
| -11.964% | |
| -40.346% | |
| -104.0942% | |
| -78.5234% | |
| -39.628% | |
| -35.3867% | |
| -44.3542% | |
| -11.6868% | |
| -3.3504% | |
| -62.7422% | |
| -55.3535% | |
| -55.5043% | |
| -95.911% | |
| -18.8008% | |
| 0.1757% | |
| 36.989% | |
| 50.3561% | |
| 45.0445% | |
| -918.9448% | |
| -638.7265% | |
| -306.0738% | |
| 49.1931% | |
| 125.3804% |